icon-folder.gif   Conference Reports for NATAP  
 
 

IDweek

Back grey_arrow_rt.gif
 
 
 
48-Week Safety and Efficacy On-Treatment Analysis of
Ibalizumab in Patients with Multi-Drug Resistant HIV-1

 
 
  Brinda Emu, MD
Yale University
Presentation
Friday, October 6
IDWeek 2017
 
Reported by Jules Levin
 
Reported by Jules Levin
IDWeek2017/IDSA, October 4-8, 2017, San Diego

1011171

1011172

1011173

1011174

1011175

1011176

1011177

1011178